Integrating Plasma Proteomics and Polygenic Risk Scores for the Prediction of Lung Cancer Risk
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70710 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Fan Yang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Institute, Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Hospital of Traditional Chinese Medicine), Nanjin…. Hauptthemen laut MEDLINE: Lung Neoplasms, Proteomics, Biomarkers, Tumor, Blood Proteins. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Jiangsu Province Science and Technology Plan Project Key R&D Program, the Medical Research Program of Health Commission of Jiangsu Province, Academic Promotion Special Project of Department Director.
Abstract (Originalsprache)
Multimodal diagnostic strategies and risk stratification are essential for improving early lung cancer detection, clinical outcomes, and personalized interventions. To develop a predictive model for lung cancer incidence by integrating plasma proteomics, genetic factors, and demographic data. We analyzed data from the UK Biobank, which included 47,655 adults without a history of lung cancer at baseline, with 641 incident cases and a median follow‐up duration of 13.87 years. COX proportional hazards modeling with SHapley Additive exPlanations (SHAP) sequential feature selection was used to identify significant plasma proteins associated with lung cancer. An XGBoost‐based survival model was constructed and evaluated to assess its predictive utility. Proteomic risk score (ProRS), demographic, and Combined risk scores were developed to evaluate their predictive capabilities across genetic risk strata. Among 2911 plasma proteins, we identified 15 significant plasma proteins associated with the development of lung cancer. The XGBoost survival model demonstrated promising predictive performance, achieving a C‐statistics of 0.803. Risk stratification revealed that high‐risk groups had up to a 101‐fold increased risk of lung cancer compared to low‐risk groups. We analyzed expression patterns of 15 carcinogenesis‐associated proteins during the 15‐year period preceding diagnosis. TNR and CLEC3B were identified as the earliest dysregulated proteins, with expression levels consistently downregulated beginning as early as 14 years before diagnosis. GDF15 exhibited sustained and pronounced upregulation throughout the entire 14‐year observation window. Integrating plasma proteomics, polygenic risk scores, and demographic factors improves personalized lung cancer risk stratification, offering potential for refined screening strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Institute, Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Hospital of Traditional Chinese Medicine), Nanjing, China.
- Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
- Department of Respiratory and Critical Medicine, Affiliated Hospital of Nanjing, University of Chinese Medicine (Jiangsu Hospital of Traditional Chinese Medicine), Nanjing, China.
- GCP Center, Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Hospital of Traditional Chinese Medicine), Nanjing, China.
- Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.
- Department of Science & Technology, Biobank of Jiangsu Cancer Hospital, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
ORCID-Profile: Rong Yin, Xiaoxiao Wang
Förderung
- Jiangsu Province Science and Technology Plan Project Key R&D Program
- the Medical Research Program of Health Commission of Jiangsu Province
- Academic Promotion Special Project of Department Director
- Open Project of Jiangsu Province Science and Technology Resources Integrated Service Platform
- Open Project of Jiangsu Provincial Traditional Chinese Medicine Epidemic Disease Research Center
Zitieren
APA
Yang, F., Qiu, X., Wang, W., Wang, Y., Wang, S., Wang, J., Hu, X., Wang, Y., Chen, F., Qi, H., Zuo, X., Zhu, J., Jiang, M., Yin, R., & Wang, X. (2026). Integrating Plasma Proteomics and Polygenic Risk Scores for the Prediction of Lung Cancer Risk. International Journal of Cancer. https://doi.org/10.1002/ijc.70710
Vancouver
Yang F, Qiu X, Wang W, Wang Y, Wang S, Wang J, et al. Integrating Plasma Proteomics and Polygenic Risk Scores for the Prediction of Lung Cancer Risk. International Journal of Cancer. 2026. doi:10.1002/ijc.70710
BibTeX
@article{Yang2026,
author = {Yang, Fan and Qiu, Xirui and Wang, Wei and Wang, Yifan and Wang, Siwei and Wang, Jie and Hu, Xinru and Wang, Yingtian and Chen, Fangyi and Qi, Haining and Zuo, Xianglin and Zhu, Junru and Jiang, Meng and Yin, Rong and Wang, Xiaoxiao},
title = {Integrating Plasma Proteomics and Polygenic Risk Scores for the Prediction of Lung Cancer Risk},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70710}
}
EUVIMED